HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma

Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York

UPMC Cancer Centers, Pittsburgh

St. Luke's Hospital, Anderson Campus, Easton

Emory University School of Medicine, Atlanta

MSMC Research Program, Miami Beach

Case Comprehensive Cancer Center, Cleveland

The Christ Hospital Cancer Center, Cincinnati

Indiana University, Indianapolis

University of Michigan, Comprehensive Cancer Center, Ann Arbor

Karmanos Cancer Institute, Detroit

University of Iowa Hospitals and Clinics, Iowa City

University of Minnesota Masonic Cancer Center, Minneapolis

Luther General Cancer Care Institute, Park Ridge

Loyola University Medical Center, Div of Hematology/Oncology, Maywood

Hematology/Oncology Clinic, Baton Rouge

University Arizona Cancer Center, Tucson

Moores UCSD Cancer Center, La Jolla

Providence Cancer Center, Portland

University of Kansas, Kansas City

Dartmouth-Hitchcock Medical Center, Lebanon

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack